BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27813341)

  • 1. Pharmacological and biological therapeutic strategies for osteogenesis imperfecta.
    Marom R; Lee YC; Grafe I; Lee B
    Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):367-383. PubMed ID: 27813341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteogenesis imperfecta and achievements in cell and gene therapy].
    Marijanović I; Radnić M; Matić I; Erceg-Ivkosić I
    Acta Med Croatica; 2010 Jul; 64(3):191-200. PubMed ID: 20922862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenesis imperfecta: an update on clinical features and therapies.
    Marom R; Rabenhorst BM; Morello R
    Eur J Endocrinol; 2020 Oct; 183(4):R95-R106. PubMed ID: 32621590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.
    Jacobsen CM; Schwartz MA; Roberts HJ; Lim KE; Spevak L; Boskey AL; Zurakowski D; Robling AG; Warman ML
    Bone; 2016 Sep; 90():127-32. PubMed ID: 27297606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenesis imperfecta: diagnosis and treatment.
    Biggin A; Munns CF
    Curr Osteoporos Rep; 2014 Sep; 12(3):279-88. PubMed ID: 24964776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fracture Healing in Collagen-Related Preclinical Models of Osteogenesis Imperfecta.
    Zieba J; Munivez E; Castellon A; Jiang MM; Dawson B; Ambrose CG; Lee B
    J Bone Miner Res; 2020 Jun; 35(6):1132-1148. PubMed ID: 32053224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenesis imperfecta: practical treatment guidelines.
    Antoniazzi F; Mottes M; Fraschini P; Brunelli PC; Tatò L
    Paediatr Drugs; 2000; 2(6):465-88. PubMed ID: 11127846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy approaches for osteogenesis imperfecta.
    Niyibizi C; Wang S; Mi Z; Robbins PD
    Gene Ther; 2004 Feb; 11(4):408-16. PubMed ID: 14724682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the evaluation and treatment of osteogenesis imperfecta.
    Harrington J; Sochett E; Howard A
    Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteogenesis imperfecta - A clinical update.
    Tournis S; Dede AD
    Metabolism; 2018 Mar; 80():27-37. PubMed ID: 28625337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.
    Xia XY; Cui YX; Huang YF; Pan LJ; Yang B; Wang HY; Li XJ; Shi YC; Lu HY; Zhou YC
    Clin Chim Acta; 2008 Dec; 398(1-2):148-51. PubMed ID: 18755172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta.
    Ho Duy B; Zhytnik L; Maasalu K; Kändla I; Prans E; Reimann E; Märtson A; Kõks S
    Hum Genomics; 2016 Aug; 10(1):27. PubMed ID: 27519266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.
    Sinder BP; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
    Bone; 2015 Feb; 71():115-23. PubMed ID: 25445450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the Classification and Treatment of Osteogenesis Imperfecta.
    Thomas IH; DiMeglio LA
    Curr Osteoporos Rep; 2016 Feb; 14(1):1-9. PubMed ID: 26861807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment.
    Sato A; Ouellet J; Muneta T; Glorieux FH; Rauch F
    Bone; 2016 May; 86():53-7. PubMed ID: 26927310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
    Gajko-Galicka A
    Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
    Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
    Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic causes and mechanisms of Osteogenesis Imperfecta.
    Lim J; Grafe I; Alexander S; Lee B
    Bone; 2017 Sep; 102():40-49. PubMed ID: 28232077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COL1A1 mutation analysis in Lithuanian patients with osteogenesis imperfecta.
    Benusiené E; Kucinskas V
    J Appl Genet; 2003; 44(1):95-102. PubMed ID: 12590186
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.